Letters
The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: Comment on the article by Moreland et al
Niels Graudal MD, DMSc,
Niels Graudal MD, DMSc
Copenhagen University Hospital, Rigshospitalet, Denmark
Search for more papers by this author Gesche Jürgens MD, PhD,
Gesche Jürgens MD, PhD
Copenhagen University Hospital, Bispebjerg, Denmark
Search for more papers by this author
Niels Graudal MD, DMSc,
Niels Graudal MD, DMSc
Copenhagen University Hospital, Rigshospitalet, Denmark
Search for more papers by this author Gesche Jürgens MD, PhD,
Gesche Jürgens MD, PhD
Copenhagen University Hospital, Bispebjerg, Denmark
Search for more papers by this author
First published: 02 November 2012
No abstract is available for this article.
- 1
Moreland LW,
O'Dell JR,
Paulus HE,
Curtis JR,
Bathon JM,
St.Clair EW, et al.
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the Treatment of Early Aggressive Rheumatoid Arthritis trial.
Arthritis Rheum
2012;
64:
2824–35.
- 2
Van der Heijde DM.
How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000;27:261–3].
J Rheumatol
1999;
26:
743–5.
- 3
Goekoop-Ruiterman YP,
de Vries-Bouwstra JK,
Allaart CF,
van Zeben D,
Kerstens PJ,
Hazes JM, et al.
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.
Arthritis Rheum
2005;
52:
3381–90.
- 4
Graudal N,
Jurgens G.
Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.
Arthritis Rheum
2010;
62:
2852–63.
- 5
Ma MH,
Kingsley GH,
Scott DL.
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.
Rheumatology (Oxford)
2010;
49:
91–8.
- 6
Van Vollenhoven RF,
Geborek P,
Forslind K,
Albertsson K,
Ernestam S,
Petersson IF, et al.
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.
Lancet
2012;
379:
1712–20.
